Clinical trials
Phase 4 Pharyngitis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2007 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Unknown status | 6 |
| Not yet recruiting | 2 |
| Recruiting | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boehringer Ingelheim | 2 |
| Albany Medical College | 1 |
| Ankara University | 1 |
| Ascension Health | 1 |
| Bayer | 1 |
| Beni-Suef University | 1 |
| Chang Gung Memorial Hospital | 1 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 1 |
| Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 1 |
| Hospital Fernandez | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pharyngitis | 24 |
| Tonsillitis | 4 |
| Pain | 2 |
| Postoperative Nausea and Vomiting | 2 |
| Bronchitis | 1 |
| Common Cold | 1 |
| Cough | 1 |
| Deglutition Disorders | 1 |
| Gastroenteritis | 1 |
| Inflammation | 1 |
Trials
Showing 76 to 24 of 24. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.